PeptideStack
5.2kquestions
20kanswers
220users

How do I trace a Homopeptide lot number back to a synthesis date?

Asked 22 Dec 2025Modified 4 months agoViewed 14k times
14

The lot number on the vial matches the certificate, which at least rules out the easy problem.

I have done this once and I suspect I got away with it rather than got it right.

For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.

What would you do, and what would you check afterwards?

batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
shareeditfollowflag
AD
askedanouk_desmet16k3822 Dec 2025

5 Answers

Accepted answer first, then by votes
43

Accepted answer

The single most misleading statement on a research-grade certificate is a lot number with no statement of how many vials from that lot were tested.

If the entire lot failed qualification, a retest on a different vial is sometimes done, but reporting a retest result under the same lot number is misleading.

If the lot was manufactured in multiple batches, testing vials from each batch separately establishes whether batch-to-batch variation is acceptable.

Lyophilised peptide homogeneity studies show that vial-to-vial variation is usually small but occasionally large, depending on the distribution in the freeze-dryer.

If testing multiple vials, state how many you tested and why you chose those vials.

edited 13 Mar 2026 by j_wierzbicki — corrected a unit error in the worked example

shareimprove this answerflag
JW
answered · acceptedj_wierzbicki69k14810 Mar 2026
7The system-suitability data is the part that tells you whether to believe the rest. – shear_at_the_front 10 months ago
add a comment
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
36

Worth being precise here: two vials tested from a lot of ten is very different from two vials tested from a lot of ten thousand, and most certificates do not state the lot size.

The sample size determination requires choosing a confidence level and an acceptable error rate, and the smaller the error rate you want, the larger your sample must be.

The relevant detail is that acceptance Sampling by Attributes defines the number of samples you need from a lot to claim a specified quality level at a specified risk — it is in ANSI standard Z1.4.

Sampling plans for pharmaceutical manufacturing are defined in ISO 2859 and ANSI Z1.4, and they are based on statistical sampling theory.

The practical summary: a lot number without a sampling statement is a lot number without meaning.

edited 13 Mar 2026 by kirsi_lahtinen — added a caveat about sampling

shareimprove this answerflag
KL
answeredkirsi_lahtinen25k2726 Feb 2026
2Any reason to prefer ion chromatography over fluorine NMR for the counter-ion here? – amara_nwachukwu 9 months ago
I would gently push back on the second point — inter-laboratory spread is wider than stated. – b_delacroix 8 months ago
add a comment
17

A certificate that reports one test result on one vial extrapolates to claim that all two hundred vials in the lot are identical, which is an assumption worth questioning.

Testing a vial that has been open in the lab for three months is testing aged material, not the fresh lot, and the result should be explicitly noted as a retest.

Specifically, stratified sampling — testing one vial from the top, one from the middle, and one from the bottom of a shipment — is cheap insurance against segregation.

One qualification: testing more vials gives better confidence, but at some point the cost outweighs the benefit.

Assume segregation is possible, and design your sampling to catch it if it exists.

shareimprove this answerflag
TM
answeredtobias_maartens171k3584 Feb 2026
14

Concretely, sampling plans exist precisely because testing everything is expensive, and they define the statistical relationship between sample size and lot-wide inference.

Under AQL sampling plans, testing two vials from a fifty-vial lot gives you an operating characteristic curve that tells you what risks you are accepting.

The limitation is that you cannot know for certain without testing every vial, and you almost never can afford to do that.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

shareimprove this answerflag
RC
answeredRP_C18105k34816 Feb 2026
5Which wavelength was the purity integrated at? It changes the number more than people think. – w_okoye 8 months ago
add a comment
11

More usefully, thermal history during shipping is different for every vial, so a lot that experienced thermal abuse may have internal variation even if it was originally homogeneous.

A statement that "lot 20260412 complies with specifications" is meaningless without stating which vials from the lot were tested and how many there were.

Published data on lot homogeneity from manufacturers who sample multiple vials consistently find variation below the published specifications, suggesting the sampling plans work.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.

shareimprove this answerflag
AL
answereda_lindgren58k24812 Apr 2026

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.